Full Length Research Paper
References
Adu S, Amankwaa Y (2005). Epidemiology of trichomoniasis in Kumasi, Ghana. PhD thesis, London School of Hygiene & Tropical Medicine. | ||||
Adu-Sarkodie Y, Steiner MJ, Attafuah J, Tweedy K (2000). Syndromic management of urethral discharge in Ghanaian pharmacies. Sex Transm. Infect. 76(6):439-42. Crossref |
||||
Cotch MF, Pastorek JG, 2nd, Nugent RP (1997). Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal In-fections and Prematurity Study Group. Sex Transm. Dis. 24:353–60. Crossref |
||||
Thomason JL, Gelbart SM, Sobun JF, Schulien MB, Hamilton PR (1988) Comparison of four methods to detect Trichomonas vaginalis. J. Clin. Microbiol. 26(9):1869–1870. Pubmed |
||||
Bowden FJ, Paterson BA, Mein J, Savage J, Fairley CK, Garland SM, Tabrizi SN (1999). Estimating the prevalence of Trichomonas vaginalis, Chlamydia trachomatis, Nisseria gonorrhoeae, and human papilloma virus infection in indigenous women in northern Australia. Sex Transm. Infect. 75:431-4. Crossref |
||||
Cohen J (2000). HIV transmission - AIDS researchers look to Africa for new insights. Science 287:942. Crossref |
||||
Forna F, Gülmezoglu AM (2003). Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev. CD000218. Crossref |
||||
Franklin AN, Harold WB (1994). Basic Clinical Parasitology. pp. 42-44. | ||||
Heine P, McGregor JA (1993). Trichomonas vaginalis: a reemerging pathogen. Clin. Obstet. Gynecol. 36:137–44. Crossref |
||||
Helms DJ, Mosure DJ, Metcalf CA, Douglas JM Jr, Malotte CK, Paul SM, Peterman TA (2008). Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics. Sex Transm. Dis. 35(5):484-8. Crossref |
||||
Kaydos S, Swygard H, Wise SL, Sena AC, Leone PA, Miller WC, Cohen MS, Hobbs MM (2002). Development and validation of a pcr-based enzyme-linked immunosorbent assay with urine for use in clinical research settings to detect Trichomonas vaginalis in women. J. Clin. Microbiol. 40:89-95. Crossref |
||||
Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn Jr, WC (1992). Colour Atlas and Textbook of Diagnostic Microbiology, Fourth Edition. P 87. | ||||
Lo M, Reid M, Brokenshire M (2002). Epidemiological features of women with trichomoniasis in Auckland sexual health clinics: 1998-99. J. N. Z Med. J. 115(1159):U119. Pubmed |
||||
AIDS Control and Prevention (AIDSCAP) (1997). Making Prevention Work. Global Lessons Learned from the AIDS Control and Prevention (AIDSCAP) Project 1991-1997. pp.19-25. | ||||
Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA (2002). Medical Microbiology, 4th Edition. P 703. | ||||
Petrin D, Delgaty K, Bhatt R, et al (1998). Clinical and microbiological aspects of Trichomonas vaginalis. Clin. Microbiol. Rev.11:300–17. Pubmed |
||||
Soper D (2004). Trichomoniasis: under control or undercontrolled? Am. J. Obstet. Gynecol. 190(1):281-90. Crossref |
||||
Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L (2007). The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004. Clin. Infect. Dis. 45(10):1319-26. Crossref |
||||
Sylvia SM (1997). Inquiry into Life- 8th Edition. pp 555. | ||||
Upcroft P, Upcroft JA (2001). Drug targets and mechanisms of resistance in the anaerobic protozoa. Clin. Microbiol. Rev. 14:150-164. Crossref |
||||
Wang CC, McClelland RS, Reilly M, Overbaugh J, Emery SR, Mandaliya K (2001). The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J. Infect. Dis. 183(7):1017-22. Crossref |
||||
World Health Organization, WHO (2001). Global Prevalence and Incidence of Selected Curable Sexually Transmitted Infections: Overviews and Estimates. WHO/HIV_AIDS/2001.02. Geneva: World Health Organization. |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0